| ■ 英語タイトル：Global Embolotherapy Market Size study & Forecast, by Product (Embolic Agents, Support Devices) by Procedure (Transcatheter Arterial Embolization (TAE), Selective Internal Radiation Therapy (SIRT), Trans arterial Chemoembolization (TACE)), by Disease indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological, Nephrological Disorders, Gastrointestinal Disorders), by End user (Hospitals, Clinics, Ambulatory Surgery Centers, Others) and Regional Analysis, 2022-2029
|
 | ■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23JUN081
■ 発行日：2023年5月
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
|
■ 販売価格オプション
（消費税別）
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
*** レポート概要（サマリー）***Bizwit Research社の本調査レポートでは、2021年にXX億ドルであった世界の動脈塞栓術市場規模が、2022年〜2029年にかけてCAGR（年平均成長率）XX%で成長すると展望しています。本資料は、動脈塞栓術の世界市場にフォーカスし、市場現状や今後の動向について整理した資料です。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（塞栓剤、サポート装置）分析、手術別（経カテーテル動脈塞栓術、選択的内部放射線療法、経動脈的化学塞栓療法）分析、疾患別（がん、末梢血管疾患、神経疾患、泌尿器疾患、その他）分析、エンドユーザー別（病院、診療所、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなど、以下の構成でまとめています。また、Imbiotechnologies Ltd.、Johnson & Johnson、Kaneka Corporation、Medtronic Plc、Meril Life Sciences Pvt. Ltd.、Merit Medical Systems, Inc.、Penumbra, Inc.、Simbionix USA Corporation、Sirtex Medical Limited、Stryker Corporationなど、主要な市場参入企業情報を含んでいます。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の動脈塞栓術市場規模：製品別
- 塞栓剤の市場規模
- サポート装置の市場規模
・世界の動脈塞栓術市場規模：手術別
- 経カテーテル動脈塞栓術の市場規模
- 選択的内部放射線療法の市場規模
- 経動脈的化学塞栓療法の市場規模
・世界の動脈塞栓術市場規模：疾患別
- がんの市場規模
- 末梢血管疾患の市場規模
- 神経疾患の市場規模
- 泌尿器疾患の市場規模
- その他疾患の市場規模
・世界の動脈塞栓術市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の動脈塞栓術市場規模：地域別
- 北米の動脈塞栓術市場規模
- ヨーロッパの動脈塞栓術市場規模
- アジア太平洋の動脈塞栓術市場規模
- 中南米の動脈塞栓術市場規模
- その他地域の動脈塞栓術市場規模
・競争分析
・調査プロセス |
Global Embolotherapy Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Embolotherapy is a minimally invasive medical procedure that involves the use of embolic agents to block blood vessels or blood flow in order to treat a variety of medical conditions. Embolic agents can be solid particles, gels, or liquids that are injected directly into a blood vessel, causing the vessel to clot and preventing blood from flowing to a specific area of the body. Embolotherapy is used to treat a variety of conditions, including uterine fibroids, liver tumors, aneurysms, and vascular malformations. The technique is minimally invasive than traditional surgery and can be performed on an outpatient basis in some cases, with shorter recovery times and fewer complications. The key factor driving the market growth is rising demand for the minimally invasive surgical procedures, favorable reimbursement scenario for minimally invasive surgeries and growing technological advancement in embolotherapy devices.
The rising demand for minimally invasive surgical procedures is anticipated to support the growth of the embolotherapy market. Embolotherapy is a minimally invasive technique used to treat a wide range of medical conditions, including cancer, uterine fibroids, aneurysms, and vascular malformations. According to Statista, in 2019, the minimally invasive surgery market globally was valued USD 20.5 billion and it is anticipated to reach USD 44.04 billion by 2030. As a result, the rising demand for the minimally invasive surgical procedures is anticipated to propel the market growth. Additionally, the growing target patient population and rising funding & investment by government and private organizations for the medical and health care facility development is anticipated to create the lucrative opportunity for the market during projected period. However, the lack of sufficient evidence & unfavorable regulatory scenario, and strong market positioning of alternative therapies stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Embolotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market holding the largest market share, owing to the presence of key market players, favorable reimbursement policies, and growing investments for the healthcare facility development. Whereas, Asia Pacific is anticipated to exhibit fastest growing region during forecasted period over the forecast period, owing to factors such as booming medical tourism, developing healthcare network and increasing research and development activities in the region would create lucrative growth prospects for the Embolotherapy market across Asia Pacific region.
Major market player included in this report are:
Imbiotechnologies Ltd.
Johnson & Johnson
Kaneka Corporation
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Merit Medical Systems, Inc.
Penumbra, Inc.
Simbionix USA Corporation
Sirtex Medical Limited
Stryker Corporation
Recent Developments in the Market:
In 2021, Terumo Corporation has received FDA approval for the PMA Supplement for the WEB 17 System, a novel component of the WEB Aneurysm Embolisation System for the treatment of intracranial wide-neck bifurcation aneurysms.
Global Embolotherapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Procedure, Disease indication, End user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Embolic Agents
Support Devices
By Procedure:
Transcatheter Arterial Embolization (TAE)
Selective Internal Radiation Therapy (SIRT)
Trans arterial Chemoembolization (TACE)
By Disease indication:
Cancer
Peripheral Vascular Disease
Neurological Diseases
Urological
Nephrological Disorders
Gastrointestinal Disorders
By End user:
Hospitals
Clinics
Ambulatory Surgery Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Embolotherapy Market, by region, 2019-2029 (USD Billion)
1.2.2. Embolotherapy Market, by Product, 2019-2029 (USD Billion)
1.2.3. Embolotherapy Market, by Procedure, 2019-2029 (USD Billion)
1.2.4. Embolotherapy Market, by Disease indication, 2019-2029 (USD Billion)
1.2.5. Embolotherapy Market, by End user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Embolotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Embolotherapy Market Dynamics
3.1. Embolotherapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising demand for the minimally invasive surgical procedures
3.1.1.2. Favourable reimbursement scenario for minimally invasive surgeries
3.1.1.3. Growing technological advancements in embolotherapy devices
3.1.2. Market Challenges
3.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
3.1.2.2. Strong market positioning of alternative therapies
3.1.3. Market Opportunities
3.1.3.1. Growing target patient populations
3.1.3.2. Rising funding & investment by government and private organizations
Chapter 4. Global Embolotherapy Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Embolotherapy Market, by Product
6.1. Market Snapshot
6.2. Global Embolotherapy Market by Product, Performance – Potential Analysis
6.3. Global Embolotherapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Embolotherapy Market, Sub Segment Analysis
6.4.1. Embolic Agents
6.4.2. Support Devices
Chapter 7. Global Embolotherapy Market, by Procedure
7.1. Market Snapshot
7.2. Global Embolotherapy Market by Procedure, Performance – Potential Analysis
7.3. Global Embolotherapy Market Estimates & Forecasts by Procedure 2019-2029 (USD Billion)
7.4. Embolotherapy Market, Sub Segment Analysis
7.4.1. Transcatheter Arterial Embolization (TAE)
7.4.2. Selective Internal Radiation Therapy (SIRT)
7.4.3. Trans arterial Chemoembolization (TACE)
Chapter 8. Global Embolotherapy Market, by Disease indication
8.1. Market Snapshot
8.2. Global Embolotherapy Market by Disease indication, Performance – Potential Analysis
8.3. Global Embolotherapy Market Estimates & Forecasts by Disease indication 2019-2029 (USD Billion)
8.4. Embolotherapy Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Peripheral Vascular Disease
8.4.3. Neurological Diseases
8.4.4. Urological
8.4.5. Nephrological Disorders
8.4.6. Gastrointestinal Disorders
Chapter 9. Global Embolotherapy Market, by End user
9.1. Market Snapshot
9.2. Global Embolotherapy Market by End user, Performance – Potential Analysis
9.3. Global Embolotherapy Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
9.4. Embolotherapy Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgery Centers
9.4.4. Others
Chapter 10. Global Embolotherapy Market, Regional Analysis
10.1. Embolotherapy Market, Regional Market Snapshot
10.2. North America Embolotherapy Market
10.2.1. U.S. Embolotherapy Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Procedure breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. End user breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Embolotherapy Market
10.3. Europe Embolotherapy Market Snapshot
10.3.1. U.K. Embolotherapy Market
10.3.2. Germany Embolotherapy Market
10.3.3. France Embolotherapy Market
10.3.4. Spain Embolotherapy Market
10.3.5. Italy Embolotherapy Market
10.3.6. Rest of Europe Embolotherapy Market
10.4. Asia-Pacific Embolotherapy Market Snapshot
10.4.1. China Embolotherapy Market
10.4.2. India Embolotherapy Market
10.4.3. Japan Embolotherapy Market
10.4.4. Australia Embolotherapy Market
10.4.5. South Korea Embolotherapy Market
10.4.6. Rest of Asia Pacific Embolotherapy Market
10.5. Latin America Embolotherapy Market Snapshot
10.5.1. Brazil Embolotherapy Market
10.5.2. Mexico Embolotherapy Market
10.5.3. Rest of Latin America Embolotherapy Market
10.6. Rest of The World Embolotherapy Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Imbiotechnologies Ltd.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Johnson & Johnson
11.2.3. Kaneka Corporation
11.2.4. Medtronic Plc
11.2.5. Meril Life Sciences Pvt. Ltd.
11.2.6. Merit Medical Systems, Inc.
11.2.7. Penumbra, Inc.
11.2.8. Simbionix USA Corporation
11.2.9. Sirtex Medical Limited
11.2.10. Stryker Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
*** 免責事項 ***https://www.globalresearch.co.jp/disclaimer/
